Alvotech gets new FDA review for Humira biosimilar

cafead

Administrator
Staff member
  • cafead   Sep 20, 2023 at 11:22: PM
via The Food and Drug Administration is reviewing Alvotech’s newest application for its Humira biosimilar, setting a Feb. 24 deadline to decide on approval, the company said Wednesday. The regulator has twice rejected the drug because of manufacturing issues at an Iceland plant.

article source